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Structural determinants of 
5′,6′-epoxyeicosatrienoic acid 
binding to and activation of TRPV4 
channel
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Marín  3, Fernando González-Nilo2,4, José M. Fernández-Fernández  1 & Miguel A. Valverde1
TRPV4 cation channel activation by cytochrome P450-mediated derivatives of arachidonic acid 
(AA), epoxyeicosatrienoic acids (EETs), constitute a major mechanisms of endothelium-derived 
vasodilatation. Besides, TRPV4 mechano/osmosensitivity depends on phospholipase A2 (PLA2) 
activation and subsequent production of AA and EETs. However, the lack of evidence for a direct 
interaction of EETs with TRPV4 together with claims of EET-independent mechanical activation of 
TRPV4 has cast doubts on the validity of this mechanism. We now report: 1) The identification of an EET-
binding pocket that specifically mediates TRPV4 activation by 5′,6′-EET, AA and hypotonic cell swelling, 
thereby suggesting that all these stimuli shared a common structural target within the TRPV4 channel; 
and 2) A structural insight into the gating of TRPV4 by a natural agonist (5′,6′-EET) in which K535 
plays a crucial role, as mutant TRPV4-K535A losses binding of and gating by EET, without affecting 
GSK1016790A, 4α-phorbol 12,13-didecanoate and heat mediated channel activation. Together, our 
data demonstrates that the mechano- and osmotransducing messenger EET gates TRPV4 by a direct 
action on a site formed by residues from the S2-S3 linker, S4 and S4-S5 linker.
The transient receptor potential vanilloid 4 (TRPV4) is a widely expressed nonselective cation channel that 
shows a polymodal gating behavior1, 2. TRPV4 is activated by physical stimuli such as hypotonicity3–5, mechan-
ical forces6–8, moderate heat9–11 or UVB radiation12, and by both natural (epoxyeicosatrienoic acids, EETs13, 14  
and bisandrographolide15) and synthetic agonists (e.g., 4α-phorbol 12,13-didecanoate (4α-PDD)16 and 
GSK1016790A17). Due to this gating promiscuity, TRPV4 participates in multiple physiological processes, includ-
ing cellular5, 18 and systemic volume homeostasis19, 20, endothelial function and angiogenesis14, 21–23, epithelial 
hydroelectrolyte transport24, nociception25, bladder voiding26, ciliary beat frequency regulation8, 27, innate immu-
nity28, matrix stiffness29, cartilage maintenance and chondroprotection30, 31, and bone development32.
Intracellular lipid metabolites are important modulators of TRPV4 gating: Phosphatidylinositol 
4,5-bisphosphate (PIP2) binding to a stretch of positive charges within the N-tail of each cannel subunit is required 
for TRPV4 activation by hypotonicity and heat11 while EETs derived from AA promote TRPV4 opening13. EETs 
also appear to act as messengers that mediate TRPV4 activation in response to either hypoosmotic shock33 or 
mechanical stimulation8, 34. In this regard, PLA2 is activated by hypotonic and mechanical stimulation35, 36 but 
no direct measurements of EETs have been reported in response to these stimuli. Besides, EETs constitute a 
major type of endothelium-derived hyperpolarizing factors that promote vascular relaxation through two plau-
sible mechanisms involving TRPV4. First, EETs induce TRPV4-mediated Ca2+ influx into smooth muscle cells 
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that ends in the activation of large conductance Ca2+-gated K+ (BKCa) channels, resulting in direct smooth mus-
cle hyperpolarization and vasodilation14, 37. Second, autocrinally released EETs promote TRPV4-mediated Ca2+ 
entry in endothelial cells21 that stimulates the activity of small and intermediate conductance Ca2+-gated K+ (SKCa 
and IKCa) channels, causing endothelial-dependent vascular relaxation38–40. Moreover, activation of the cerebro-
spinal fluid Na+ level sensor NaX in brain glial cells produces EETs that lead to the activation of TRPV4-positive 
neurons in sensory circumventricular organs to induce water intake41.
EETs are also modulators of other ion channels such as the ATP-sensitive K+ channel Kir6.242, the BKCa channel43, 
L-type voltage-gated Ca2+ channels44 or the epithelial Na+ channel ENaC45. Depending on the channel, the effect 
of EETs is produced either by their direct interaction with a specific channel site42 or through different intracel-
lular signaling pathways43–45. However, despite the physiological relevance of TRPV4 modulation by EETs, it is 
still unknown how EETs ultimately activate TRPV4. We now combine molecular simulations along with binding 
assays and functional studies to provide strong evidences supporting that EET-induced TRPV4 gating is due to 
direct EET binding to a crevice formed by helical segments S1 through S4 of each TRPV4 subunit, with a critical 
role of the K535 residue located at the S2-S3 linker in the stabilization of the ligand position.
Results
To gain structural insights into the potential direct interaction of 5′,6′-epoxyeicosatrienoic acid (5′,6′-EET) 
with the TRPV4 channel we combined in silico molecular docking with molecular dynamics (MD) simula-
tions. Docking poses clustered in 4 cavities in TRPV4, representing a unique binding site defined in the TRPV4 
four-fold symmetry. The TRPV4 residues within 5 Å of the 100 docking poses are highlighted in the sequence 
shown in Supplementary Fig. 1. The docking energy ranged from −6.0 to −7.2 kcal/mol. This initial docking was 
further refined using smaller docking boxes (20 Å × 20 Å × 20 Å) around the defined binding site, to obtain lower 
binding energy values. The docking solution presented (Supplementary Fig. 2) represents the docking pose (out 
of 10) with the lowest energy (−7.4 kcal/mol), where TRPV4 residues within a distance of 3.5 Å of 5′,6′-EET are 
indicated. To evaluate the stability of the configuration determined by the in silico docking and further explore 
the interactions between 5′,6′-EET and TRPV4, a 120 ns MD simulation (Fig. 1a) was performed based on a pre-
viously reported TRPV4 model46 and using the configuration shown in Supplementary Fig. 2 as starting point. 
Based on the most frequent interactions, i.e., residues showing more than 60% of time occupancy (displayed in 
licorice representation in Fig. 1b,c), MD simulation identified a 5′,6′-EET binding site in the TRPV4-WT system 
conformed by residues from S2-S3 linker (K535, F549 and Q550), S4 (Y591) and S4-S5 linker (R594) (Fig. 1a–c, 
f and Supplementary Fig. 3) that were also predicted by the in silico docking. These residues, which are conserved 
throughout evolution (Supplementary Fig. 4), re-direct the 5′,6′-EET′s aliphatic chain upwards. Among those 
Figure 1. Predicted model of TRPV4 channel interaction with 5′,6′-EET. (a) TRPV4 structural model 
showing only two of the four identical subunits (side view). Color-coded transmembrane segments S1-S4, 
TRP box and EET molecule are highlighted. Images of the predicted EET-binding site in TRPV4-WT (b,c) and 
TRPV4 K535A (d,e) systems. Residues showing more than 60% of time occupancy are displayed in licorice 
representation. K535A residue from TRPV4 K535A is displayed in licorice representation even though its 
interaction is not significant. (f,g) Bottom view detail of the interaction of 5′,6′-EET with residues K535 and 
R594 in the TRPV4-WT (f) and TRPV4-K535A (g) systems. Note the loss of interaction between mutated 
residue A535 and both D743 and EET molecule.
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residues, amino acids K535 and R594 seem to play a crucial role as they face the 5′,6′-EET carboxylic group to 
stabilize ligand position (Fig. 1f and Supplementary Fig. 3). Residue K535 also generates a salt bridge with D743 
in the TRP box (Fig. 1f).
In order to test the relevance of these two residues in 5′,6′- EET binding we set a MD simulation in which 
5′,6′-EET was added to a channel with K535 mutated to A535 (TRPV4-K535A). The 120 ns simulation reported 
the loss of the interaction between 5′,6′-EET and residue A535 (Fig. 1d,e) as well as the salt bridge between resi-
dues 535 and 743 (Fig. 1g). All these facts suggest a loss of stability of the 5′,6′-EET position in the TRPV4-K535A 
system, which correlates with the values of the root-mean square deviation of atomic positions (RMSD) calcu-
lated in both systems: TRPV4-WT + EET, 3.4 ± 0.5 Å and TRPV4-K535A + EET, 4.2 ± 0.8 Å (mean ± S.D., n = 4). 
Molecular dynamic simulations using TRPV4-K535Q and TRPV4-R594Q systems (to neutralize charges at those 
residues) were also run and, similar to the TRPV4-K535A, demonstrated loss of stability of the 5′,6′-EET posi-
tion in these two systems (Supplementary Fig. 3). In the absence of 5′,6′-EET no lipids were observed in the EET 
binding pocket of the TRPV4-WT or TRPV4-K535A systems (Supplementary Fig. 5).
In order to test the physical interaction between 5′,6′-EET and TRPV4 and to evaluate the predicted rele-
vance of residue K535, we used the microscale thermophoresis (MST) assay. MST records the migration behavior 
of fluorescently labeled proteins in a microscopic temperature gradient, which is influenced by any interacting 
molecule. Thus, fluorescence changes in a heated spot of the GFP-tagged TRPV4 protein containing solution are 
measured as a function of increasing concentration of the non-fluorescent 5′,6′-EET, allowing the estimation 
of Kd values. Figure 2a shows fluorescence traces obtained for TRPV4-WT-GFP and TRPV4-K535A-GFP pro-
teins at four representative 5′,6′-EET concentrations. The change in thermophoresis, expressed as the change in 
the normalized fluorescence (ΔFNorm), upon increasing concentrations of 5′,6′-EET yielded a binding curve for 
TRPV4-WT-GFP with a Kd of 12.8 ± 4 μM (Fig. 2b). In the case of TRPV4-K535A, data did not fit to a binding 
curve in the range of agonist concentration tested, suggesting the lack of interaction between 5′,6′-EET and the 
mutant channel (Fig. 2b).
Residue R594 has been previously implicated in general channel gating as its mutation prevents channel activ-
ity in response to many different stimuli47, an observation we also report now (Supplementary Fig. 6) that pre-
cludes further functional studies on the role of this residue in the interaction of EET with the TRPV4 protein. 
Nevertheless, the relevance of residue R594 to the TRPV4 interaction with EET was also evaluated by MST assays 
(Supplementary Fig. 7). GFP and TRPV4–R594A-GFP proteins showed similar MST responses. Maximal ΔFNorm 
values obtained with GFP and TRPV4–R594A-GFP proteins were significantly smaller than those obtained with 
TRPV4-WT-GFP.
Figure 2. Thermophoretic analysis of the TRPV4-EET interaction. (a) Typical signal of a microscale 
thermophoresis (MST) experiment showing the thermophoretic movement (induced by infrared laser 
activation, arrow) of the GFP-labeled TRPV4 WT or K535A mutant channel and the subsequent fluorescence 
change measured for 30 s in the presence of increasing concentrations of 5′,6′-EET, from 27 nM (blue trace) to 
225 µM (red trace). GFP-TRPV4 channels and 5′,6′-EET were incubated for 30–60 min in PBS, with 2% ethanol 
as vehicle. (b) Average changes in normalized fluorescence obtained for GFP-labeled TRPV4 WT (n = 4) and 
K535 (n = 4) channels plotted against 5′,6′-EET concentration and fitting of the TRPV4-WT data.
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Both the molecular dynamics and MST data indicated that the TRPV4-K535A channel has lost its ability to 
bind 5′,6′-EET. To test whether this was also translated to an impaired channel response to EET we combined 
calcium imaging and patch-clamp techniques to evaluate channel activity. First, we showed that TRPV4-WT 
(Fig. 3a) showed similar pattern of expression than TRPV4-K535A channel (Fig. 3b) as well as co-localization to 
the plasma membrane, identified with the plasma membrane marker concanavalin A in transfected HeLa cells. 
Both TRPV4–WT and TRPV4–K535A channels showed similar overlapping plot profiles with concanavalin A 
(Fig. 3c) with no differences in the Pearsons correlation coefficients (Fig. 3d).
By using intracellular Ca2+ imaging with Fura-2, we evaluated the sensitivity to 5′,6′-EET (1 μM), heat (38 °C) 
and the synthetic agonist GSK1016790A (10 nM) of TRPV4-WT, TRPV4-K535A and TRPV4-K535Q channels 
heterologously expressed in HeLa cells. Addition of 1 μM 5′,6′-EET evoked a significant [Ca2+]i response in cells 
transiently transfected with TRPV4-WT but not in cells expressing TRPV4-K535A (Fig. 4a,b) or TRPV4-K535Q 
(Supplementary Fig. 8a) mutant channels, whose response to 5′,6′-EET was indistinguishable from that obtained 
in control GFP-transfected cells or in TRPV4-transfected cells treated with vehicle (Fig. 4a,b and Supplementary 
Fig. 8a). In contrast, K535A or K535Q mutations had no significant effect on the TRPV4-mediated [Ca2+]i 
responses to heat, GSK1016790A (Fig. 4c–e and Supplementary Fig. 8c-e) or 4α-PDD (Supplementary Fig. 9). 
Besides, the TRPV4-mediated increase of [Ca2+]i in response to AA, the EETs precursor, was also lost in cells 
transfected with mutant channels (Supplementary Fig. 8b).
Consistent with the calcium imaging measurements, the use of electrophysiological techniques demonstrated 
that 5′,6′-EET (Fig. 5a,b) and AA (Supplementary Fig. 10) only increased channel activity in HEK293 cells tran-
siently transfected with TRPV4-WT but not in cells expressing TRPV4-K535A or TRPV4-K535Q mutant chan-
nels. Moreover, supporting the idea that TRPV4 activation by osmotic stress depends mostly on phospholipase A2 
(PLA2) activation, AA production and its subsequent metabolism to EET 33, mutation K535A strongly reduced 
TRPV4 whole-cell currents elicited by a 30% hypotonic shock (Fig. 5c,d). TRPV4-mediated whole-cell currents 
elicited by GSK1016790A (0.1, 10 and 100 nM) were unaffected by mutation K535A (Fig. 5e,f).
Two more residues (F549 and Q550), in close proximity to K535, that in the 120 ns MD trajectory also showed 
frequent interactions with 5′,6′-EET ( > 60% of the time) were mutated (F549A and Q550A) and tested for their 
response to AA, heat and GSK1016790A (Supplementary Fig. 11a-c). While TRPV4-Q550A seems to be a dead 
channel, unresponsive to all three stimuli, TRPV4-F549A showed reduced response to GSK1016790A without 
significant changes in the response to AA and heat. We also mutated residue D743, which establishes a salt bridge 
with K535. TRPV4-D743Q channel showed a reduced response to GSK1016790A but normal activity when chal-
lenged with 1 μM 5′,6′-EET (Supplementary Fig. 11d-e).
Finally, we assessed whether changes in the size of the TRPV4 channel pore caused by 5′,6′-EET binding 
could be observed during MD simulation and may be affected by the K535A mutation. For that purpose, using 
both TRPV4 WT and K535A systems in the absence and presence of 5′,6′-EET, we measured the area determined 
by a square formed by the four α-carbons of I715 residues (Fig. 6). These residues are located at the narrowest 
zone of TRPV4 pore and are homologous to I679 residues that in the TRPV1 structure form a hydrophobic 
seal (lower gate) that expands in the presence of channel agonists48, 49. For all four systems studied, the area 
started at the same value (~55Å2), and only for the TRPV4 WT system in the presence of 5′,6′-EET (Fig. 6b) 
Figure 3. Mutation K535A does not alter membrane localization of heterologously expressed TRPV4 channels. 
Co-localization of TRPV4-WT (a) and TRPV4-K535A (b) channels (green) expressed in HeLa cells with the 
plasma membrane marker concanavalin A (magenta). Co-localized pixels are shown in white in the merge 
panels. The yellow line on the merge panels indicates the plot profile analysis (c) performed on each image using 
ImageJ software. Scale bar = 20 μm. (d) Pearson correlation coefficients obtained with the plot profile analysis 
of TRPV4-WT and TRPV4-K535A channels in the plasma membrane location. Mean ± S.E.M., P = 0.1 Mann-
Whitney.
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the area increased from 55.5 ± 2.9 Å2 up to 63.8 ± 4.2 Å2 (mean ± S.D.: P = 0.0001 as determined by one way 
ANOVA followed by a Bonferroni post hoc test). Besides, the opening of the pore in the presence of 5′,6′-EET 
was unrelated to changes in the distance between Cα of residues W733 and R594 (WT: 8.0 ± 0.56 in the absence 
and 7.8 ± 0.59 in the presence of 5′,6′-EET, mean ± S.D.; P > 0.05) or L596 (WT: 5.9 ± 0.5 in the absence and 
5.6 ± 0.3 in the presence of 5′,6′-EET, mean ± S.D.; P > 0.05), which has been recently linked to alterations in 
channel activity50. In the TRPV4-K535A system, the presence of 5′,6′-EET did not increase the area (56.4 ± 4.4 
Å2 versus 53 ± 2.6 Å2, in the absence and presence of 5′,6′-EET, respectively) (Fig. 6c,d). Accordingly, only in the 
pore of the TRPV4-WT + EET system (Fig. 7) was possible to observe water molecules crossing the hydrophobic 
seal formed by I715. Together, our results support the view that 5′,6′-EET binds TRPV4 and its sufficient to gate 
channel opening.
Discussion
TRPV4 channel gating by EETs is physiologically relevant in the context of vasodilatation14, 21, 37, 38, 51–54. In the 
brain, glial cells sense high Na+ levels to produce EETs that in turn activate neuronal TRPV4 to trigger water 
intake 41 and the homeostatic control of body fluid osmolarity. Besides, TRPV4 mechano/osmosensitivity 
depends on PLA2 activation and the subsequent production of the P450-mediated AA metabolites, EETs8, 33, 34. 
However, the lack of evidence for a direct interaction of EET with TRPV4 and claims of EET-independent acti-
vation of TRPV4 by AA55 and mechanical stimulation56, 57 have cast doubts on the validity of this mechanism.
Figure 4. TRPV4-K535A channel loses activation by 5′,6′-EET not by heat or GSK1016790A agonist. (a) 
Changes in intracellular [Ca2+] (indicated by normalized fura-2 ratios) in HeLa cells transfected with GFP, 
TRPV4-WT or TRPV4-K535A cDNAs, after perfusion with 1 µM 5′,6′-EET or vehicle (as indicated). Traces are 
means ± SEM of 74–163 cells measured in 4–8 independent experiments. (b) Average [Ca2+]i increases (area 
under the curve) from traces shown in a. Numbers inside the bars indicate the number of cells analyzed. (c) 
Changes in intracellular [Ca2+] in response to warm solution (38 °C). (d) Average [Ca2+]i increases (area under 
the curve) from traces shown in c. (e) Changes in intracellular [Ca2+] in response to 10 nM GSK1016790A 
(GSK). Traces are means of 93–109 cells measured in 4–6 independent experiments. *P < 0.05 or not significant 
(n.s.) when compared with cells expressing TRPV4 WT channels (Kruskal-Wallis followed by Dunn post hoc 
test).
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Our study presents two major findings: 1) The identification of an EET-binding pocket at the TRPV4 
channel that specifically participates in the channel activation by 5′,6′-EET, AA and hypotonic cell swelling, 
thereby supporting the view that all these stimuli shared a common final structural target within the TRPV4 
channel; although we do not discard other modes of swelling-induced TRPV4 activation as the response of the 
TRPV4-K535A channel to hypotonic stimulation is not completely abrogated; and 2) The first structural insight 
into the gating of TRPV4 by a natural (lipidic) agonist (5′,6′-EET).
The EET binding site identified involves residues from S2-S3 linker (K535, F549 and Q550), S4 (Y591) and 
S4-S5 linker (R594). Remarkably, all these amino acids are conserved throughout evolution and, among these 
residues, K535 plays a crucial role in 5′,6′-EET binding to TRPV4, as the mutant TRPV4-K535A channel loses 
the capability of binding 5′,6′-EET and the response to 5′,6′-EET, AA and hypotonicity, without affecting TRPV4 
gating by temperature or the TRPV4 agonists GSK1016790A and 4α-PDD. Consistent with a direct and suffi-
cient interaction of 5′,6′-EET with TRPV4 to activate the channel, molecular dynamics simulation showed that 
5′,6′-EET triggers pore opening of the TRPV4-WT but not the TRPV4-K535A channel.
To date, the structures of two members of the vanilloid family (TRPV1 and TRPV2)48, 49, 58, 59 have been resolved 
with high, near-atomic resolution, and many of their features are considered to be shared by TRPV446, 50, 60. 
These structural studies have identified two putative lipid binding sites in rabbit TRPV2. One is located near the 
C-terminal portion of S4 (from N509 to R514, a region highly conserved between human TRPV1, TRPV2 and 
TRPV4 (Figure supplement 12)), the S4-S5 linker and the S6 of an adjacent subunit58. A similar lipid binding 
site has been reported for rat TRPV1, which overlaps with the binding-pocket for capsaicin and other vanilloid 
Figure 5. Effect of K535A substitution on the activation of TRPV4 whole-cell currents. Representative ramp 
current desnsity-voltage relations of whole-cell cationic currents recorded from HEK293 cells transfected with 
either TRPV4 WT or TRPV4 K535A cDNAs before (control) and after dialysis with 500 nM 5′,6′-EET (a), 
exposition to a 30% hypotonic shock (c) or to 10 nM GSK1016790A (e). (b,d,f) Average TRPV4 current density 
(at + 100 mV) increases in response to the above indicated stimuli. Data are expressed as the mean ± SEM, and 
the number of cells recorded is shown for each experimental condition. **P < 0.01, *P < 0.05 K535A versus 
WT. P values in panel b = 0.007, panel d = 0.002 and > 0.05 at al concentrations in panel f (One-tailed Student′s 
unpaired t test).
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ligands59. In addition, comparison of TRPV1 structural data obtained in the absence (closed state) and presence 
of resiniferatoxin (a capsaicin analog) suggest that channel activation by vanilloids entails the displacement of 
the resident lipid, the stabilization of vanilloid binding by Y511 (at S3) and the vanilloid-coordinated interaction 
between two residues (R557 and E570) to pull the S4-S5 linker and facilitate opening of the lower gate. This model 
is supported by functional studies showing that R557 and E570 mutations impairs the allosteric coupling between 
the voltage-, temperature- and capsaicin-dependent TRPV1 activation mechanisms, which is partially restored by 
the charge-swapping double mutation R557E/E570R61. It is worth mentioning that R557 is a conserved residue 
among human TRPV1, TRPV2 (R515) and TRPV4 (R594). Moreover, R594 (along with the S4 residue Y591, 
which we have identified in the EET-binding pocket) has been reported to play a general role in the transduc-
tion of chemical stimuli into TRPV4 gating 47, an observation we also reproduce here (Supplementary Fig. 6). 
Consistent with this important function, TRPV4 mutations of R594 that promote TRPV4 basal activity have 
clinical consequences in the context of skeletal dysplasias62.
The other reported TRPV2 lipid binding site, has been placed in the crevice formed by the S1-S4 helical 
bundle58, a location that also accommodates lipids in the TRPV1 structure48, 59. The TRPV4 EET-binding site 
we now report also relates to this crevice formed by segments S1 through S4. Among the S1-S4 amino acids we 
have identified within a distance of 3.5 Å of 5′,6′-EET, Y591 is identical in both TRPV1 and TRPV2 channels 
(Supplementary Fig. 12). Of particular relevance, residue K535, with a key role in the EET binding-induced 
TRPV4 gating, corresponds to Q498 in TRPV1 (Supplementary Fig. 12), a change (K to Q) that abrogates TRPV4 
response to 5′,6′-EET, and that might account for the EET-insensitivity of TRPV1.
The S1-S4 TRPV4 cleft containing the EET-binding pocket is placed above the TRP box domain, and accord-
ing to TRPV1 and TRPV2 structural data it is a hot spot for controlling channel gating. Actually, the interaction 
of the agonist 4α-PDD with TRPV4 has also been positioned at the pocket between S3 and S4 segments and of 
the three amino acids (Y556, L584 and W586) 47 involved in such interaction, Y556 is also one of the residues 
frequently interacting with 5′,6′-EET in the TRPV4-WT MD simulation. How EET and 4α-PDD interaction with 
TRPV4 leads to channel opening remains to be elucidated. Previous TRPV4 MD simulations showed that W733 
(TRP box) usually interacts with L596 (but also with R594, in the S4-S5 linker) and that changes in this distance 
will disrupt the latch that keeps the channel close promoting its aperture50. Considering that R594 is one of the 
key residues for EET binding, we speculated that agonist-induced conformational changes might increase the 
distance between W733 (sited at the TRP box) and L596 or R594 (both positioned at the S4-S5 linker) to open 
Figure 6. K535A substitution prevents the 5′,6′-EET-induced change in TRPV4 pore dimension. Pore area 
delimited by the square formed by the four Cα of I715 residues (located at the narrowest zone of TRPV4 pore). 
(a) TRPV4-WT; (b) TRPV4-WT + 5′,6′-EET; (c) TRPV4-K535A; (d) TRPV4-K535A + 5′,6′-EET.
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the channel. However, we could not detect changes in this distance in the presence of 5′,6′-EET in any of the MD 
systems analyzed.
In conclusion, we show here, for the first time, that direct 5′,6′-EET binding to TRPV4 gates the channel. 
We have located the EET-binding pocket in close relationship with segments S2-S3 linker through S4, into the 
S1-S4 crevice above the TRP box, with partial overlapping with the predicted binding site of 4α-PDD between 
S3 and S4. Moreover, the fact that mutant TRPV4-K535A channel loses EET binding and EET-, AA- and 
hypotonicity-induced activation without affecting GSK, 4α-PDD and temperature activation suggested a com-
mon structural motif within TRPV4 that is targeted by the swelling-PLA2-AA-EET pathway.
Methods
Cells and transfections. For electrophysiological or calcium imaging experiments HeLa and HEK293 cells 
were transiently transfected with human TRPV4 wild-type/mutant cDNAs cloned in the pcDNA3.1 vector as 
previously described34.
Confocal microscopy. Cells transiently transfected with human TRPV4 wild-type or mutants (in a 
pcDNA3.1 vector were stained with 100 μg/ml of the plasma membrane marker concanavalin A tetramethyl-
rhodamine (Invitrogen) for 20 min on ice and then fixed with 4% paraformaldehyde and probed with a polyclonal 
affinity-purified anti-human TRPV4 (1:1000)63 at room temperature for 1 hour. Digital images were taken and 
analyzed using a Leica TCS SP2 and the National Institutes of Health Image J software (http://rsb.info.nih.gov/ij/).
TRPV4 Docking and Molecular Dynamics Simulations. Human TRPV4 and 5′,6′-EET were pre-
pared for docking using the DockPrep tool in UCSF Chimera64. The docking calculations were performed 
with the AutoDock Vina tool (Scripps Research Institute, La Jolla, CA)65 included in UCSF Chimera. 10 dock-
ing rounds providing 10 docking poses each (total of 100 docking poses) were initially performed using a 
100 Å × 100 Å × 50 Å docking box around the cytosol-bilayer interface of TRPV4. Further docking refinement 
was performed using smaller docking boxes (20 Å × 20 Å × 20 Å) around the defined binding site, to obtain larger 
binding energy values.
All MD systems analyzed were based on a previously reported TRPV4 MD system46. The putative EET loca-
tion predicted by the docking pose with higher energy (−7.4 kcal/mol), with the grid located at the mass center 
of residue 400, was used as starting point for subsequent MD simulations. In the presence of 5′,6′-EET, the force 
Figure 7. K535A substitution abolishes the 5′,6′-EET-induced water flux through TRPV4 pore. Water presence 
around I715 residue in TRPV4-WT (a), TRPV4-WT + EET (b), TRPV4-K535A (c), and TRPV4-K535A + EET 
(d) systems. Insets: Water molecules crossing the hydrophobic seal formed by I715 are observed exclusively in 
the TRPV4-WT + EET system.
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field parameters were obtained from ParamChem66. Harmonic restraints of 1 kcal/mol/Å2 were initially set on the 
α-carbons of the secondary structure and were diminished by 0.2 kcal/mol/Å2 in periods of 1 ns. Subsequently, 
120 ns of trajectory were obtained. All calculations were run using NAMD 2.967.
Microscale Thermophoresis. MST analysis was performed using a NanoTemper Monolith NT.115 
instrument, as previously described68. Briefly, C-tail tagged TRPV4-WT-GFP-His, TRPV4-K535A-GFP-His, 
TRPV4-R594A-GFP-His and GFP-His were solubilized from HEK293 cells transfected with pCD-
NA3-TRPV4-GFP-His or pCDNA3-TRPV4-K535A-GFP-His and treated with a lysis buffer containing: 2% 
DDM, 300 mM NaCl, 50 mM Tris HCl, pH8.0. Subsequently, proteins of interest were enriched by FPLC using 
Ni-NTA columns (HisTrap FF Crude, GE Healthcare Life Sciences). The different fractions were separated by 
an imidazole gradient (0–500 mM): buffer A (0.025% DDM, 150 mM NaCl, 50 mM TrisHCl, pH8.0) + buffer 
B (0.025% DDM, 150 mM NaCl, 50 mM Tris-HCl, 500 mM imidazole). A concentration of 20 nM TRPV4 or 
TRPV4-K535A was incubated in the dark with different concentrations of 5′,6′-EET (Santa Cruz Biotechnology, 
USA) in Buffer A (0.025% DDM, 150 mM NaCl, 50 mM Tris HCl, pH8.0) containing 2% ethanol as vehicle. The 
samples were loaded into standard glass capillaries (Monolith NT.115 Capillaries) and thermophoresis analysis 
was performed (LED 40%, IR laser 80%). Dissociation constants were calculated using the NanoTemper 1.2.206 
analysis program.
Ratiometric Ca2+ Measurements, Electrophysiological Recordings and Solutions. Cytosolic 
Ca2+ signals, relative to the fluorescence ratio (340/380) measured prior to cell stimulation, were obtained from 
transfected HeLa cells loaded with 4.5 μM fura-2 AM (Invitrogen) as previously described34. Isotonic bath solu-
tions used for Ca2+ imaging experiments contained 140 mM NaCl, 2.5 mM KCl, 1.2 mM CaCl2, 0.5 mM MgCl2, 
5 mM glucose, and 10 mM HEPES (pH 7.3, adjusted with Tris).
For patch-clamp whole-cell recordings on transfected HEK293 cells, bath solutions contained 100 mM 
NaCl, 1 mM MgCl2, 6 mM CsCl, 10 mM HEPES, 1 mM EGTA, and 5 mM glucose (pH 7.3, adjusted with Tris). 
Osmolarity was adjusted to 310 mOsm/L adding D-mannitol (isotonic solution) and 30% hypotonic solution 
(220 mOsm/L) were obtained by omitting D-mannitol. Borosilicate glass electrodes (2–3 MΩ) were filled with 
a solution contained 20 mM CsCl2, 100 mM CsAcetate, 1 mM MgCl2, 0.1 mM EGTA, 10 mM HEPES, 4 mM 
Na2ATP, and 0.1 mM NaGTP; 300 mOsm/L (pH 7.25, adjusted with CsOH). When required, 500 nM 5,6-EET 
was added to this intrapipette solution. Home-made local perfusion69 was used to deliver TRPV4 agonist 
(GSK1016790A, Tocris Bioscience, UK), antagonist (HC067047, Tocris Bioscience, UK) and solutions of differ-
ent osmolality.
TRPV4 activity was assessed with a 400 ms ramp from −100 mV to +100 mV using a D-6100 Darmstadt 
(List Medical, Germany) amplifier and pClamp 8 software (Molecular Devices, USA). The ramp protocol was 
applied every 5 seconds in the absence (control) or presence of TRPV4 stimuli. TRPV4-specific responses were 
always validated using the TRPV4 inhibitor HC067047 (10 µM) in presence of the selected activating stimuli. 
Cell-attached recordings were obtained from patches in EGFP-positive HEK293 cells 2 days after transfection 
with cDNA encoding wild-type (WT), K535A or K535Q mutant TRPV4 channels, clamped at +80 mV using a 
gap-free protocol and an Axopatch 200 A (Molecular Devices, U.S.A.) or an EPC10-USB patch-clamp amplifier 
(HEKA, Germany). Borosilicate glass patch pipettes had a tip resistance of 4–5 MΩ and were filled with a solution 
containing 140 mM NaCl, 1 mM MgCl2, 5 mM CsCl, 1 mM EGTA, 5 mM Glucose and 10 mM HEPES (310 mOs-
m/L, pH 7.35). The bath solution contained 140 mM KCl (to zero the membrane potential), 1 mM MgCl2, 5 mM 
Glucose, and 10 mM HEPES (300 mOsm/L, pH 7.4 adjusted with Tris).
The pClamp10.5, PatchMaster, FitMaster, Fetchan and pStat softwares were employed for voltage-clamp, data 
acquisition, and subsequent analysis of all electrophysiological data. Whole-cell and cell-attached currents were 
recorded at 10 kHz and low-pass-filtered at 1 kHz. Cell-attached activity of WT and mutants TRPV4 channels was 
assessed as the NPO (number of channels x single channel open probability) from 15 seconds continuous record-
ings at +80 mV obtained in the presence of extracellular arachidonic acid or the corresponding vehicle (DMSO, 
1:500 dilution), which were added to the intrapipette solution.
Electrophysiological and ratiometric Ca2+ recordings were obtained at room temperature (24 °C), unless oth-
erwise indicated.
All chemicals were obtained from Sigma-Aldrich unless otherwise indicated.
Statistical Analysis. Data are expressed as mean ± SEM (unless otherwise indicated). Statistical analysis was 
assessed with Student′s unpaired t test, Mann-Whitney U-test, one way analysis of variance (ANOVA) followed 
by Bonferroni post hoc test, or Kruskal-Wallis test followed by Dunn post hoc test, as appropriate. Differences were 
considered significant if P < 0.05.
Data Availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
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